Cargando…
Functional nucleic acids as potent therapeutics against SARS-CoV-2 infection
The COVID-19 pandemic has posed a severe threat to human life and the global economy. Although conventional treatments, including vaccines, antibodies, and small-molecule inhibitors, have been broadly developed, they usually fall behind the constant mutation of SARS-CoV-2, due to the long screening...
Autores principales: | Chen, Jingran, Li, Ying, Liu, Zhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s).
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869493/ https://www.ncbi.nlm.nih.gov/pubmed/36714073 http://dx.doi.org/10.1016/j.xcrp.2023.101249 |
Ejemplares similares
-
Nucleic Acid Vaccines against SARS-CoV-2
por: Liu, Ying, et al.
Publicado: (2022) -
Functional nucleic acids as modular components against SARS-CoV-2: From diagnosis to therapeutics
por: Zhang, Wenxian, et al.
Publicado: (2022) -
Nucleic Acid Testing of SARS-CoV-2
por: Yoo, Hee Min, et al.
Publicado: (2021) -
Identification of Potent and Safe Antiviral Therapeutic Candidates Against SARS-CoV-2
por: Xiao, Xia, et al.
Publicado: (2020) -
Targeting SARS-CoV-2 Variants with Nucleic Acid Therapeutic Nanoparticle Conjugates
por: Huber, Hanah F., et al.
Publicado: (2021)